IREN
IREN Limited
There isn't enough reported data to score IREN yet.
PSEC
Prospect Capital Corporation
There isn't enough reported data to score PSEC yet.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
PSEC Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| N/A | |
| N/A |
PSEC's profitability is currently stable, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like PSEC.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
PSEC PE Valuation
PSEC has no meaningful PE right now: it lost money over the past year.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
IREN has the edge over PSEC on the outlook, with more favorable revenue and profitability expectations.
PSEC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect PSEC's earnings and revenue to decline, with profitability weakening.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has the stronger earnings trend. Trailing diluted EPS is down 347% for IREN versus PSEC down 505%.
PSEC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.32 | — |
| Q3 2025 | -$0.89 | -$0.67 |
| Q2 2025 | -$1.35 | -497% |
| Q1 2023 | -$0.51 | -124% |
| Q4 2022 | $0.14 | -94% |
| Q3 2022 | $0.62 | -76% |
| Q2 2022 | $1.41 | -44% |
| Q1 2022 | $2.14 | -7.8% |
| Q4 2021 | $2.39 | +103% |
PSEC lost $0.89 per share over the past year, a bigger loss than the year before.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the stronger quarterly revenue trend. Revenue is down 5.1% for IREN versus down 104% for PSEC.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
PSEC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2022 | $203.3M | -32% |
| Q4 2021 | $293.9M | -17% |
| Q3 2021 | $253.7M | +19% |
| Q2 2021 | $284.3M | +37% |
| Q4 2020 | $353.2M | +753% |
PSEC's revenue has slid since its 2020 peak: −$11M last quarter, down 104% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2022 | 81% | -1.9 points |
| Q4 2021 | 86% | -0.3 points |
| Q3 2021 | 84% | +4.6 points |
| Q2 2021 | 86% | +7.2 points |
| Q1 2021 | 83% | N/A |
| Q4 2020 | 87% | +114 points |
| Q3 2020 | 79% | N/A |
| Q2 2020 | 79% | N/A |
PSEC's operating margin was 81% last quarter, down 1.9 points from the same quarter a year ago.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
PSEC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $381.7M | +37% |
| Q2 2026 | -$43.9M | -$36.3M |
| Q1 2026 | $195.7M | +149% |
| Q4 2025 | $85.6M | -69% |
| Q3 2025 | $279M | +61% |
| Q2 2025 | -$7.6M | -106% |
| Q1 2025 | $78.6M | +$100.8M |
| Q4 2024 | $278.5M | +251% |
PSEC has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has the edge over PSEC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
PSEC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -44% | -405M shares |
| 1 year | +18% | +81M shares |
| 3 years | -4.2% | -22.9M shares |
| 5 years | +37% | +143M shares |
| Available history | +43% | +157M shares |
PSEC has 524M diluted shares, up 18% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
PSEC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 4.7x | High |
| Q1 2022 | 2.9x | Moderate |
| Q4 2021 | 2.4x | Moderate |
| Q3 2021 | 2.0x | Moderate |
| Q2 2021 | 2.3x | Moderate |
| Q1 2021 | 2.3x | Moderate |
| Q4 2020 | 4.6x | High |
| Q3 2020 | 16.0x | High |
PSEC's net debt is about 4.7 years of its operating earnings (EBITDA), up from 2.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like PSEC.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
PSEC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.3 | Oversold |
| Stochastic | 13.6 | Oversold |
PSEC's weekly RSI is 26 (oversold) and its Stochastic is 14 (oversold).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
PSEC PE vs Financial Services Sector
| Metric | PSEC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
PSEC has no meaningful PE right now: it lost money over the past year.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has the edge over PSEC on trend strength, trading above more of its moving averages.
PSEC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.68 | 16% below |
| 20 week MA | $2.01 | 30% below |
| 50 week MA | $2.36 | 40% below |
| 100 week MA | $2.91 | 52% below |
| 200 week MA | $4.40 | 68% below |
PSEC is in a downtrend: it's below all five of its weekly moving averages, and 68% below its 200-week average.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
PSEC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.51 | $5.46 | -16% |
| 2021 | $5.46 | $8.43 | +54% |
| 2022 | $8.43 | $7.16 | -15% |
| 2023 | $7.16 | $5.99 | -16% |
| 2024 | $5.99 | $4.26 | -29% |
| 2025 | $4.26 | $2.51 | -41% |
| 2026 YTD | $2.51 | $1.41 | -44% |
PSEC has the edge over IREN on returns for 2026, with the stronger performance.